574 related articles for article (PubMed ID: 18328360)
1. Sympathetic-leptin relationship in obesity: effect of weight loss.
Quilliot D; Böhme P; Zannad F; Ziegler O
Metabolism; 2008 Apr; 57(4):555-62. PubMed ID: 18328360
[TBL] [Abstract][Full Text] [Related]
2. Effects of sibutramine on abdominal fat mass, insulin resistance and blood pressure in obese hypertensive patients.
Faria AN; Ribeiro Filho FF; Kohlmann NE; Gouvea Ferreira SR; Zanella MT
Diabetes Obes Metab; 2005 May; 7(3):246-53. PubMed ID: 15811141
[TBL] [Abstract][Full Text] [Related]
3. Leptin and heart sympathetic activity in normotensive obese and non-obese subjects.
Amador N; Pérez-Luque E; Malacara JM; Guízar JM; Paniagua R; Lara S
Ital Heart J; 2004 Jan; 5(1):29-35. PubMed ID: 15080578
[TBL] [Abstract][Full Text] [Related]
4. [Serum leptin and insulin resistance in obesity and effects of sibutramine on them].
Wu J; Lei MX; Chen HL
Hunan Yi Ke Da Xue Xue Bao; 2003 Dec; 28(6):605-7. PubMed ID: 15804071
[TBL] [Abstract][Full Text] [Related]
5. Potential association between endogenous leptin and sympatho-vagal activities in young obese Japanese women.
Matsumoto T; Miyatsuji A; Miyawaki T; Yanagimoto Y; Moritani T
Am J Hum Biol; 2003; 15(1):8-15. PubMed ID: 12552573
[TBL] [Abstract][Full Text] [Related]
6. Effects of short-term hypocaloric diet on sympatho-vagal interaction assessed by spectral analysis of heart rate and blood pressure variability during stress tests in obese hypertensive patients.
Ashida T; Ono C; Sugiyama T
Hypertens Res; 2007 Dec; 30(12):1199-203. PubMed ID: 18344625
[TBL] [Abstract][Full Text] [Related]
7. Gender differences in sympathetic nervous activity: influence of body mass and blood pressure.
Lambert E; Straznicky N; Eikelis N; Esler M; Dawood T; Masuo K; Schlaich M; Lambert G
J Hypertens; 2007 Jul; 25(7):1411-9. PubMed ID: 17563563
[TBL] [Abstract][Full Text] [Related]
8. Leptin levels are associated with fat oxidation and dietary-induced weight loss in obesity.
Verdich C; Toubro S; Buemann B; Holst JJ; Bülow J; Simonsen L; Søndergaard SB; Christensen NJ; Astrup A
Obes Res; 2001 Aug; 9(8):452-61. PubMed ID: 11500525
[TBL] [Abstract][Full Text] [Related]
9. Use of sibutramine in obese mexican adolescents: a 6-month, randomized, double-blind, placebo-controlled, parallel-group trial.
García-Morales LM; Berber A; Macias-Lara CC; Lucio-Ortiz C; Del-Rio-Navarro BE; Dorantes-Alvárez LM
Clin Ther; 2006 May; 28(5):770-82. PubMed ID: 16861099
[TBL] [Abstract][Full Text] [Related]
10. Effects of sibutramine-induced weight loss on cardiovascular system in obese subjects.
de Simone G; Romano C; De Caprio C; Contaldo F; Salanitri T; di Luzio Paparatti U; Pasanisi F
Nutr Metab Cardiovasc Dis; 2005 Feb; 15(1):24-30. PubMed ID: 15871847
[TBL] [Abstract][Full Text] [Related]
11. Obesity and heart rate variability in men with myocardial infarction.
Piestrzeniewicz K; Łuczak K; Lelonek M; Wranicz JK; Goch JH
Cardiol J; 2008; 15(1):43-9. PubMed ID: 18651384
[TBL] [Abstract][Full Text] [Related]
12. Body mass index is related to autonomic nervous system activity as measured by heart rate variability.
Molfino A; Fiorentini A; Tubani L; Martuscelli M; Rossi Fanelli F; Laviano A
Eur J Clin Nutr; 2009 Oct; 63(10):1263-5. PubMed ID: 19471292
[TBL] [Abstract][Full Text] [Related]
13. Leptin responses to weight loss in postmenopausal women: relationship to sex-hormone binding globulin and visceral obesity.
van Rossum EF; Nicklas BJ; Dennis KE; Berman DM; Goldberg AP
Obes Res; 2000 Jan; 8(1):29-35. PubMed ID: 10678256
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety comparative evaluation of orlistat and sibutramine treatment in hypertensive obese patients.
Derosa G; Cicero AF; Murdolo G; Piccinni MN; Fogari E; Bertone G; Ciccarelli L; Fogari R
Diabetes Obes Metab; 2005 Jan; 7(1):47-55. PubMed ID: 15642075
[TBL] [Abstract][Full Text] [Related]
15. Heart sympathetic activity and pulmonary function in obese pregnant women.
Amador-Licona N; Guízar-Mendoza JM; Juárez M; Linares-Segovia B
Acta Obstet Gynecol Scand; 2009; 88(3):314-9. PubMed ID: 19241226
[TBL] [Abstract][Full Text] [Related]
16. Impaired sympathetic response before intradialytic hypotension: a study based on spectral analysis of heart rate and pressure variability.
Pelosi G; Emdin M; Carpeggiani C; Morales MA; Piacenti M; Dattolo P; Cerrai T; Macerata A; L'abbate A; Maggiore Q
Clin Sci (Lond); 1999 Jan; 96(1):23-31. PubMed ID: 9857103
[TBL] [Abstract][Full Text] [Related]
17. Weight reduction by sibutramine in obese subjects in primary care medicine: the SAT Study.
Hauner H; Meier M; Wendland G; Kurscheid T; Lauterbach K; ;
Exp Clin Endocrinol Diabetes; 2004 Apr; 112(4):201-7. PubMed ID: 15127325
[TBL] [Abstract][Full Text] [Related]
18. High serum high-sensitivity C-reactive protein concentrations are associated with relative cardiac sympathetic overactivity during the early morning period in type 2 diabetic patients with metabolic syndrome.
Aso Y; Wakabayashi S; Nakano T; Yamamoto R; Takebayashi K; Inukai T
Metabolism; 2006 Aug; 55(8):1014-21. PubMed ID: 16839835
[TBL] [Abstract][Full Text] [Related]
19. Autonomic nervous system activity and the state and development of obesity in Japanese school children.
Nagai N; Matsumoto T; Kita H; Moritani T
Obes Res; 2003 Jan; 11(1):25-32. PubMed ID: 12529482
[TBL] [Abstract][Full Text] [Related]
20. Psychobehavioral and nutritional predictors of weight loss in obese women treated with sibutramine.
Hainer V; Kunesova M; Bellisle F; Hill M; Braunerova R; Wagenknecht M
Int J Obes (Lond); 2005 Feb; 29(2):208-16. PubMed ID: 15583700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
